期刊
CELL
卷 160, 期 4, 页码 759-770出版社
CELL PRESS
DOI: 10.1016/j.cell.2015.01.022
关键词
-
资金
- European Research Council [ERC-2011-StG-280565, ERC-2011-AdG-294678]
- Alexander von Humboldt Foundation/BMBF
- National Center for Competences in Research Synapsy, Synaptic Bases of Mental Health Disease'' Swiss National Science Foundation [3100A0-117816]
Sensitization of the capsaicin receptor TRPV1 is central to the initiation of pathological forms of pain, and multiple signaling cascades are known to enhance TRPV1 activity under inflammatory conditions. How might detrimental escalation of TRPV1 activity be counteracted? Using a genetic-proteomic approach, we identify the GABA(B1) receptor subunit as bona fide inhibitor of TRPV1 sensitization in the context of diverse inflammatory settings. We find that the endogenous GABAB agonist, GABA, is released from nociceptive nerve terminals, suggesting an autocrine feedback mechanism limiting TRPV1 sensitization. The effect of GABAB on TRPV1 is independent of canonical G protein signaling and rather relies on close juxtaposition of the GABA(B1) receptor subunit and TRPV1. Activating the GABA(B1) receptor subunit does not attenuate normal functioning of the capsaicin receptor but exclusively reverts its sensitized state. Thus, harnessing this mechanism for anti-pain therapy may prevent adverse effects associated with currently available TRPV1 blockers.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据